Hamied Ahmad Haroon MInstP MSc PhD - The University of ...

of the 19 th Annual Meeting of the European Society for Magnetic Resonance in Medicine and
Biology, Cannes, France, August 2002; abstract # 399 (POSTER) [MAGMA 15 (Suppl 1): 192]
Haroon HA, Patankar TA, Dow G, Rutherford S, Jackson A, “Relationship between vascular
endothelial permeability and histological grade in human gliomas using a novel first pass method”
Book of Abstracts of the 19 th Annual Meeting of the European Society for Magnetic Resonance
in Medicine and Biology, Cannes, France, August 2002; abstract # 133 (ORAL) [MAGMA 15 (Suppl
1): 60]
Patankar T, Haroon H, Jackson A, “Endothelial permeability measurements fail to distinguish
between tumour grade in enhancing glioma.” Proceedings of the UK Radiological Congress,
Birmingham, UK, June 2002; p 40 (ORAL)
Jackson A, Jayson G, Haroon H, Mulatero C, Julyan P, Zweit J, “MRI demonstrates changes in
tumoral capillary endothelial permeability in response to VEGF inhibition with HuMV833 anti‐VEGF
antibody” Proceedings of the UK Radiological Congress, Birmingham, UK, June 2002; p 32
(ORAL)
Haroon HA, Patankar TA, Dow G, Rutherford S, Jackson A, “Relationship between Vascular
Endothelial Permeability and Histological Grade in Human Gliomas using a Novel First Pass
Method” Proceedings of the 10 th Scientific Meeting and Exhibition of the International Society
for Magnetic Resonance in Medicine, Honolulu, Hawai’i, USA, May 2002; p 2113 (POSTER)
Haroon, HA, Buckley DL, Patankar TA, Dow G, Rutherford S, Jackson A, “A Comparison of K trans
Measurements in Gliomas obtained with a Conventional and First Pass Model” Proceedings of the
10 th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in
Medicine, Honolulu, Hawai’i, USA, May 2002; p 663 (ORAL)
2001:
Jayson GC, Mulatero C, Ranson M, Zweit J, Hastings D, Julyan P, Lawrance J, McGown A,
Jackson A, Haroon H, Hakannson L, Wagstaff J, Groenewegen G, Lehmann F, Levitt D, Tang T,
Zweirzina H, “Anti‐VEGF Antibody HuMV833: an EORTC Biological Treatment Development Group
Phase I Toxicity, Pharmacokinetic and Pharmacodynamic Study” (VM2001 Lecture.) Proceedings
of the 37 th Annual Meeting of the American Society of Clinical Oncology, San Francisco, CA, USA,
May 2001; 20: abstract #14 – VM2001 Lecture (ORAL)
http://personalpages.manchester.ac.uk/staff/hamied.haroon/ 10 / 13 07 December 2012